Skip to content
Disclosery

Linden Advisors LP: NHIV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Linden Advisors LP on NHIV, newest first. How the timeline and the estimate are built.

Linden Advisors LP held 950,000 NHIV shares at 2026-06-30 per its 13F-HR filed 2026-08-14, and reported 1,284,999 shares, 6.2%, in a 13G filed 2026-09-28.

Estimated current stake: 1,284,999 shares, 6.2% of the class

Estimated from 13G of 2026-09-28. As of 2026-09-23, 13G 0001193125-26-404422.

Shares are the reporting group's aggregate and may include entities that do not file a 13F.

The reporting persons may hold separate positions, so the group total can be higher than the largest row.

Percent of portfolio stays on the 13F for 2026-06-30.

  1. event date2026-09-23
    13G 1,284,999 shares
    Share basis changed not comparable

    6.2% of the class. Different basis (group aggregate from 13G).

    13G 0001193125-26-404422 filed by Linden Capital L.P.
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.

    The reporting persons may hold separate positions, so the group total can be higher than the largest row.

  2. period ended2026-06-30
    13F 950,000 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $9,500,000.

    13F-HR 0001193125-26-350767 filed by Linden Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec ยง4.2).